Antineoplastic Combined Chemotherapy ProtocolsBurkitt LymphomaCancer Care Facilities
Dr. John C. Reneau, MD, PhD
NPI1437590163PAC ID6002058369
- Medicare services, 2024
- 685
- Medicare patients, 2024
- 143
- Part D claims, 2024
- 81
- Publications
- 35
- Clinical trials
- 5
- Practice address
- 460 W 10th Ave, Columbus, OH 43210
- Practice phone
- Call (614) 293-2229
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
OSU Internal Medicine
Columbus, Ohio
Find Dr. Reneau's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John C. Reneau is a hematology (internal medicine) physician in Columbus, Ohio
Dr. Reneau practices at OSU Internal Medicine in Columbus, Ohio.
Dr. Reneau's NPI, 1437590163, was assigned on July 10, 2013. Dr. Reneau holds Ohio license 35.136880.
NPI and contact details
- NPI
- 1437590163NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6002058369
- NPI enumeration date
- July 10, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (614) 293-2229
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. John C. Reneau practices at OSU Internal Medicine in Columbus, Ohio
Dr. Reneau's primary practice is OSU Internal Medicine, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-2229.
- OSU Internal Medicine460 W 10th Ave, Columbus, OH 43210 · Franklin CountyPhone(614) 293-2229
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. John C. Reneau is affiliated with 3 sites of care and 1 medical group
Dr. Reneau's primary practice is OSU Internal Medicine in Columbus, Ohio. Dr. Reneau is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Reneau to 1 more hospital, named with a free account.
OSU Internal MedicinePrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. John C. Reneau's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reneau practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| OSU Internal Medicine | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Reneau practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John C. Reneau is one of 82 hematology (internal medicine) physicians in Ohio
Internal medicine is Dr. Reneau's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Reneau is licensed in Ohio.
Specialties and state licenses
- Hematology (internal medicine), OhioPrimary
Hematology (internal medicine) physicians near Dr. Reneau
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
82hematology (internal medicine) physicians in Ohio53hematology (internal medicine) physicians in Columbus
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John C. Reneau billed Medicare for 685 services in 2024
CMS data shows 685 Medicare services from Dr. Reneau across 7 procedure codes in 2024, for 143 Medicare patients. Medicare paid $48,026 for them.
Medicare services, 2024685
Medicare patients143
Paid by Medicare$48,026
Procedure codes7
Dr. Reneau's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2692024: 48380%
- Other services
- 2023: 02024: 202
Where Dr. Reneau's Medicare services took place, 2024
- In an office41460%
- In a facility27140%
Dr. Reneau compared with the Ohio median for hematology (internal medicine) physicians, 2024
- Dr. Reneau
- Ohio median
- Medicare services
- 685vs 2552.7 times
- Medicare patients
- 143vs 10635% above
- Part D claims
- 30vs 9769% below
Medians across 76 hematology (internal medicine) physicians in Ohio with Dmand AI profiles that report each measure.
Dr. Reneau's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Reneau?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reneau and other hematology (internal medicine) physicians in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John C. Reneau treated 143 Medicare patients in 2024, average age 74
CMS counts 143 Medicare patients who saw Dr. Reneau in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Reneau's median patient age at 69, with 38% women.
Medicare patients, 2024143
Average age74
Average risk score2.44
Dr. Reneau's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Reneau's Medicare patients by sex, 2024
- Women5236%
- Men9164%
Chronic conditions among Dr. Reneau's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Arthritis48%
- Ischemic heart disease41%
- Chronic kidney disease35%
- Atrial fibrillation34%
- Mood disorders34%
- Depression33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Reneau's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women38%
- Men60%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. John C. Reneau wrote 81 Medicare Part D claims in 2024
In 2024, Dr. Reneau wrote 81 Medicare Part D claims for 25 patients. 64% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $397,440 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.
Part D claims, 202481
Drugs named by CMS2
Total drug cost$397,440
Part D patients25
Dr. Reneau's Part D claims by kind of drug, 2024
- Generic52 claims64%
- Brand-name29 claims36%
Dr. Reneau's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 412024: 3027%
Drugs named by CMS: 2 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. John C. Reneau offers telehealth to Medicare patients
Dr. Reneau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reneau as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematology (internal medicine) physicians like Dr. Reneau by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John C. Reneau has 35 publications on record
Dmand AI links 35 papers to Dr. Reneau, published from 2011 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Lymphoma, B-Cell, Lymphoma, Non-Hodgkin and Skin Neoplasms. Dr. Reneau has published most often in Blood Adv. Dr. Reneau's most frequent co-authors are Robert A. Baiocchi, MD, David Alan Bond, MD and Kami J. Maddocks, MD.
Papers35
Years published2011 to 2025
Dr. Reneau's papers by year, 2011 to 2025
Topics Dr. Reneau writes about most
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Skin Neoplasms
- Immunotherapy, Adoptive
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, T-Cell, Cutaneous
- Receptors, Chimeric Antigen
- Tumor Microenvironment
Dr. Reneau's most frequent co-authors
- Robert A. Baiocchi, MD10 shared papers
- David Alan Bond, MD8 shared papers
- Kami J. Maddocks, MD8 shared papers
Recent publications by Dr. Reneau
J Hematol Oncol
Hematologic NeoplasmsImmunotherapy, AdoptiveNeoplasms, Second Primary
Arch Dermatol Res
BiopsyLymphadenopathyLymph Nodes
Antineoplastic Combined Chemotherapy ProtocolsDoxorubicinGemcitabine
Lymphoma, B-CellLymphoma, T-Cell, CutaneousSkin Neoplasms
See who Dr. Reneau researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reneau works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John C. Reneau has worked on 5 clinical trials
Dmand AI links Dr. Reneau to 5 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, T-Cell, Cutaneous, Leukemia, Prolymphocytic, B-Cell and Lymphoma, Large-Cell, Anaplastic. John Reneau sponsors the most, 2.
Clinical trials with Dr. Reneau by phase
- 2Phase 1: 2 trials
- 3Phase 2: 3 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Reneau's trials
- Lymphoma, T-Cell, Cutaneous
- Leukemia, Prolymphocytic, B-Cell
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, T-Cell, Peripheral
- Lymphomatoid Papulosis
Investigators on the most trials with Dr. Reneau
- David M. Aboulafia, MD1 shared trial
- Omar Alkharabsheh, MD1 shared trial
- Thomas Carl Anderson, MD1 shared trial
Recent clinical trials with Dr. Reneau
Precursor T-Cell Lymphoblastic Leukemia-LymphomaLymphoma, T-Cell, CutaneousMogamulizumabCyclophosphamideFludarabine
A Phase II Study of Brentuximab Vedotin and Lenalidomide in Relapsed and Refractory T-Cell Lymphomas (opens in a new tab)
CompletedPhase 2
Lymphomatoid PapulosisLymphoma, Primary Cutaneous Anaplastic Large CellBrentuximab VedotinLenalidomide
Letermovir for Cytomegalovirus Prophylaxis in Patients With Hematological Malignancies Treated With Alemtuzumab (opens in a new tab)
CompletedPhase 2
Leukemia, Prolymphocytic, B-CellLeukemia, Prolymphocytic, T-CellLetermovir
A Phase I Study of Romidepsin in Combination With Parsaclisib in Relapsed and Refractory T-Cell Lymphomas (opens in a new tab)
CompletedPhase 1
Lymphoma, Large-Cell, AnaplasticLymphoma, T-Cell, CutaneousParsaclisibRomidepsin
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) (opens in a new tab)
CompletedPhase 2
Lymphoma, T-Cell, PeripheralLymphoma, T-CellBrentuximab vedotinBendamustineDacarbazine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John C. Reneau received $28,721 in industry payments from 2021 to 2025
CMS Open Payments shows 46 general payments to Dr. Reneau from 9 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 93% of the total. Acrotech Biopharma LLC paid the most, $24,803.
General payments to Dr. Reneau by program year, 2021 to 2025
General payments to Dr. Reneau by kind, 2021 to 2025
$28.7Kin total
- Consulting fees$26,75193%
- Food and beverage$1,9707%
Companies that paid Dr. Reneau the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. John C. Reneau's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John C. Reneau
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John C. Reneau's NPI number?
Dr. John C. Reneau's NPI number is 1437590163. It was assigned on July 10, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. John C. Reneau?
Dr. John C. Reneau is a hematology (internal medicine) physician in Columbus, Ohio. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. John C. Reneau practice?
Dr. Reneau practices at 460 W 10th Ave, Columbus, OH 43210. Dr. Reneau's primary practice is OSU Internal Medicine in Columbus, Ohio. Dmand AI also links Dr. Reneau to 1 hospital.
What is Dr. John C. Reneau's office phone number?
The practice phone on file for Dr. Reneau is (614) 293-2229.
What is Dr. John C. Reneau's medical license number?
Dr. Reneau holds Ohio license 35.136880.
Which hospitals is Dr. John C. Reneau affiliated with?
Dr. Reneau is affiliated with Ohio State University Hospital. Dmand AI links Dr. Reneau to 1 more hospital.
What medical group is Dr. John C. Reneau part of?
Dr. Reneau is linked to Ohio State University Physicians.
Does Dr. John C. Reneau accept Medicare?
Yes. CMS data shows Dr. Reneau billed Medicare for 685 services in 2024, and Dr. Reneau accepts Medicare assignment.
Does Dr. John C. Reneau offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Reneau as offering telehealth services.
How many Medicare patients does Dr. John C. Reneau see?
CMS counts 143 Medicare patients who saw Dr. Reneau in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. John C. Reneau bill to Medicare?
In 2024, Dr. Reneau's most billed Medicare services were hospital inpatient care (99233), medicare service (G2211) and office visit, established patient (99215).
What drugs does Dr. John C. Reneau prescribe most?
In 2024 Medicare Part D data, Dr. Reneau's most prescribed drugs by claims were Copiktra and Levothyroxine Sodium.
Has Dr. John C. Reneau received payments from drug or device companies?
CMS Open Payments shows $28,721 in general payments to Dr. Reneau from 9 companies from 2021 to 2025. The largest total came from Acrotech Biopharma LLC.
How long has Dr. John C. Reneau been practicing?
Dr. Reneau graduated from medical school in 2013, 13 years ago.
Does Dr. John C. Reneau do research?
Dmand AI links 35 publications to Dr. Reneau, published from 2011 to 2025. Dr. Reneau has worked on 5 clinical trials.
Who does Dr. John C. Reneau publish with?
Dr. Reneau's most frequent co-authors are Robert A. Baiocchi, MD (10 shared papers), David Alan Bond, MD (8 shared papers) and Kami J. Maddocks, MD (8 shared papers).
Selling to internal medicine practices?
See hematology (internal medicine) physicians in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card